Cuijpers, P., Karyotaki, E., Reijnders, M., Purgato, M., & Barbui, C. (2018). Psychotherapies for depression in low- and middle-income countries: a meta-analysis. World Psychiatry : Official Journal of the World Psychiatric Association (WPA), 17(1), 90-101. https://doi.org/10.1002/wps.20493

Cristofalo, D., Bonetto, C., Ballarin, M., Amaddeo, F., Ruggeri, M., Nosè, M., & Barbui, C. (2018). Access to and Use of Psychiatric Services by Migrants Resettled in Northern Italy. Journal of Immigrant and Minority Health. https://doi.org/10.1007/s10903-018-0703-z (Original work published 2018)

Hanna, F., Barbui, C., Dua, T., Lora, A., Altena, van R., & Saxena, S. (2018). Global mental health: how are we doing? World Psychiatry : Official Journal of the World Psychiatric Association (WPA), 17(3), 367-368. https://doi.org/10.1002/wps.20572

Barbui, C., Dua, T., Kolappa, K., Saraceno, B., & Saxena, S. (2017). Mapping actions to improve access to medicines for mental disorders in low and middle income countries. Epidemiology and Psychiatric Sciences, 26(5), 481-490. https://doi.org/10.1017/S2045796016001165

Dua, T., Barbui, C., Patel, A., Tablante, E., Thornicroft, G., Saxena, S., & Guideline, team. W. mhGAP. (2016). Discussion of the updated WHO recommendations for mental, neurological, and substance use disorders. The Lancet. Psychiatry, 3(11), 1008-1012. https://doi.org/10.1016/S2215-0366(16)30184-5

Barbui, C., Dua, T., Kolappa, K., Saraceno, B., & Saxena, S. (2016). Access to psychotropic medicines in low-resource settings. The Lancet. Psychiatry, 3(10), 913-915. https://doi.org/10.1016/S2215-0366(16)30141-9

Barbui, C., Dua, T., Harper, M., Tablante, E., Thornicroft, G., & Saxena, S. (2015). Using GRADE to update WHO recommendations for MNS. The Lancet. Psychiatry, 2(12), 1054-6. https://doi.org/10.1016/S2215-0366(15)00456-3

Reichow, B., Servili, C., Yasamy, M., Barbui, C., & Saxena, S. (2013). Non-specialist psychosocial interventions for children and adolescents with intellectual disability or lower-functioning autism spectrum disorders: a systematic review. PLoS Medicine, 10(12), e1001572; discussion e1001572. https://doi.org/10.1371/journal.pmed.1001572

Dua, T., Barbui, C., Clark, N., Fleischmann, A., , van Ommeren, M., … Saxena, S. (2011). Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations. PLoS Medicine, 8(11), e1001122. https://doi.org/10.1371/journal.pmed.1001122

van Ommeren, M., Barbui, C., de Jong, K., Dua, T., Jones, L., Perez-Sales, P., … Saxena, S. (2011). If you could only choose five psychotropic medicines: updating the interagency emergency health kit. PLoS Medicine, 8(5), e1001030. https://doi.org/10.1371/journal.pmed.1001030